KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients

This study aims to investigate the efficacy of bevacizumab-combined chemotherapy (BCC) in Chinese stage IV colorectal cancer (CRC), and analyze the relationship between clinicopathological features with survival. Patients with stage IV CRC treated with BCC were analyzed retrospectively. 217 metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, De-cong, Shi, Yan, Wang, Yan-rong, Lv, Yao, Yan, Huan, Mao, Hui, Wang, Zhi-kuan, Wu, Zhi-yong, Shi, Wei-wei, Dai, Guang-hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662591/
https://www.ncbi.nlm.nih.gov/pubmed/29085005
http://dx.doi.org/10.1038/s41598-017-14669-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662591/
https://www.ncbi.nlm.nih.gov/pubmed/29085005
http://dx.doi.org/10.1038/s41598-017-14669-2

Ejemplares similares